Mindy Katz and Ori Ben-David review the different fill form configurations of drug delivery devices, outlining the importance of the prefilled and preloaded device configuration for self-administering patients.
Recent advances in technology are positively influencing how we take medications and manage our health. This can be seen across multiple aspects of healthcare, and in drug delivery specifically. Drug development is changing due to advances in biotechnology research, allowing new medications to be developed, symptoms to be better managed and diseases to be cured. Accordingly, we see biologic medications filling the pipelines of pharma companies, overtaking traditional oral medications and small-molecule injectable drugs.
Connected drug delivery devices are enabling patients to become more engaged in their treatments and to better manage their diseases. Smart and intuitive devices allow patients to self-administer, adhering to their prescribed therapies in the comfort of their own homes. Technology advances in various areas are positively influencing the world of drug delivery, and we can expect to see further innovation in the coming years for the benefit of patients worldwide.
DEVELOPING WEARABLE DRUG DELIVERY DEVICES
Wearable drug delivery devices, or wearable injectors, are one category of drug delivery device designed for self-administration of injectable medication. These devices align with several trends in the drug delivery market, offering a solution for the administration of large-volume and high-viscosity medications into the subcutaneous tissue in a smart and user-friendly drug delivery device.1 Sorrel Medical is focused on the development, manufacturing and commercialisation of a wearable drug delivery platform (Figure 1), utilising the company’s experience in medical devices and innovative technology solutions.